Description

CJC-1295 with DAC 5mg — Extended Half-Life GHRH Research Compound

CJC-1295 with DAC is the longer-acting version of CJC-1295. The DAC stands for Drug Affinity Complex — a molecular modification that allows the peptide to bind to albumin (a protein naturally present in blood), which significantly extends how long it remains active.

Standard CJC-1295 without DAC has a short half-life, requiring more frequent administration in research protocols. The DAC modification extends that to several days per dose. Research using CJC-1295 with DAC focuses on what happens to GH pulse patterns, IGF-1 levels, and downstream growth signals when GHRH stimulation is sustained rather than brief.

For researchers specifically studying prolonged GHRH receptor activation — rather than pulsatile GH patterns — this is the appropriate compound. The distinction between DAC and non-DAC versions is one of the most common questions in GH axis research, and it matters for protocol design.

Best For: Growth Hormone Axis

For Research Use Only (RUO). Not for human or veterinary use. Not a drug. Not intended to diagnose, treat, cure, or prevent any disease.